dr. rodriguez-abreu on the final analysis of the keynote-189 trial in nsclc
Published 4 years ago • 282 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
0:59
dr. rodriguez-abreu on updated results from the keynote-189 trial in nsclc
-
4:52
researcher comment: final analysis of keynote-189 | delvys rodriguez-abreu
-
10:32
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
10:34
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
2:25
dr. gadgeel on updated keynote-189 data in nsclc
-
6:38
the revolution in cancer treatment has begun. targeted therapies and the oncofocus dna cancer test
-
2:55
how keytruda cancer treatment works (update)
-
44:53
renal masses: inpatient and outpatient evaluations (and updates in renal cell carcinoma)
-
4:53
chemo-immunotherapy in nsclc: the keynote-189 trial
-
3:03
keynote-189 update: 4-year follow-up of fl pembro chemo metastatic nsclc
-
12:22
bridging therapy with tenecteplase or alteplase in patients with large ischemic core
-
1:08
dr. stinchcombe on the keynote-189 trial in lung cancer
-
1:22
updated outcomes of keynote-010 of pembrolizumab for nsclc
-
5:42
keynote-189: chemotherapy and pembrolizumab in mnsclc
-
5:33
significance of keynote-189 in nsclc
-
2:02
keynote-189: chemo plus pembrolizumab for nsclc
-
7:50
keynote-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic nsclc
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
5:08
the impower150 regimen
-
6:32
keynote-189: clinical implications in patients with less than 1% tumor pd-l1 expression (bmic-033)
-
1:47
dr. langer on the current state of immunotherapy in advanced nsclc
-
10:32
evaluation of tmb in keynote-189: pembrolizumab ct vs placebo ct for nonsquamous nsclc